297 related articles for article (PubMed ID: 35177083)
1. Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways.
Szilágyi SS; Amsalem-Zafran AR; Shapira KE; Ehrlich M; Henis YI
BMC Biol; 2022 Feb; 20(1):50. PubMed ID: 35177083
[TBL] [Abstract][Full Text] [Related]
2. Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors.
Olsen OE; Hella H; Elsaadi S; Jacobi C; Martinez-Hackert E; Holien T
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235336
[TBL] [Abstract][Full Text] [Related]
3. Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
Olsen OE; Wader KF; Hella H; Mylin AK; Turesson I; Nesthus I; Waage A; Sundan A; Holien T
Cell Commun Signal; 2015 Jun; 13():27. PubMed ID: 26047946
[TBL] [Abstract][Full Text] [Related]
4. BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
Olsen OE; Sankar M; Elsaadi S; Hella H; Buene G; Darvekar SR; Misund K; Katagiri T; Knaus P; Holien T
J Cell Sci; 2018 Jun; 131(11):. PubMed ID: 29739878
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
6. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
[TBL] [Abstract][Full Text] [Related]
7. The Activation of the Fibrodysplasia Ossificans Progressiva-Inducing ALK2-R206H Mutant Depends on the Distinct Homo-Oligomerization Patterns of ACVR2B and ACVR2A.
Szilágyi SS; Burdzinski W; Jatzlau J; Ehrlich M; Knaus P; Henis YI
Cells; 2024 Jan; 13(3):. PubMed ID: 38334613
[TBL] [Abstract][Full Text] [Related]
8. Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling.
Xie C; Jiang W; Lacroix JJ; Luo Y; Hao J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899497
[TBL] [Abstract][Full Text] [Related]
9. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
Bondestam J; Kaivo-oja N; Kallio J; Groome N; Hydén-Granskog C; Fujii M; Moustakas A; Jalanko A; ten Dijke P; Ritvos O
Mol Cell Endocrinol; 2002 Sep; 195(1-2):79-88. PubMed ID: 12354674
[TBL] [Abstract][Full Text] [Related]
10. Activin A/bone morphogenetic protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatin.
Korupolu RV; Muenster U; Read JD; Vale W; Fischer WH
J Biol Chem; 2008 Feb; 283(7):3782-90. PubMed ID: 18056265
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
Glister C; Kemp CF; Knight PG
Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
[TBL] [Abstract][Full Text] [Related]
12. Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads.
Candia AF; Watabe T; Hawley SH; Onichtchouk D; Zhang Y; Derynck R; Niehrs C; Cho KW
Development; 1997 Nov; 124(22):4467-80. PubMed ID: 9409665
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein 2 stimulates noncanonical SMAD2/3 signaling via the BMP type 1A receptor in gonadotrope-like cells: implications for FSH synthesis.
Wang Y; Ho CC; Bang E; Rejon CA; Libasci V; Pertchenko P; Hébert TE; Bernard DJ
Endocrinology; 2014 May; 155(5):1970-81. PubMed ID: 24601881
[TBL] [Abstract][Full Text] [Related]
14. Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells.
Rejon CA; Hancock MA; Li YN; Thompson TB; Hébert TE; Bernard DJ
Cell Signal; 2013 Dec; 25(12):2717-26. PubMed ID: 24018044
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
Tsuchida K; Nakatani M; Uezumi A; Murakami T; Cui X
Endocr J; 2008 Mar; 55(1):11-21. PubMed ID: 17878607
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
Upton PD; Davies RJ; Trembath RC; Morrell NW
J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
[TBL] [Abstract][Full Text] [Related]
17. Regulatory roles of bone morphogenetic proteins and glucocorticoids in catecholamine production by rat pheochromocytoma cells.
Kano Y; Otsuka F; Takeda M; Suzuki J; Inagaki K; Miyoshi T; Miyamoto M; Otani H; Ogura T; Makino H
Endocrinology; 2005 Dec; 146(12):5332-40. PubMed ID: 16150914
[TBL] [Abstract][Full Text] [Related]
18. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
Aykul S; Martinez-Hackert E
J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
[TBL] [Abstract][Full Text] [Related]
19. Formation of stable homomeric and transient heteromeric bone morphogenetic protein (BMP) receptor complexes regulates Smad protein signaling.
Marom B; Heining E; Knaus P; Henis YI
J Biol Chem; 2011 Jun; 286(22):19287-96. PubMed ID: 21471205
[TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
